News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
107last 24h
3127last 7d
512● bullish (7d)
311● bearish (7d)
227publishers
Insider Monkey10h agoneutral
Johnson & Johnson (JNJ): Limited Analyst Upside, but Management Sees a Clearer Path to GrowthInsider Monkey12h agobullish
Democrats Win Midterms: 5 Best Healthcare and Insurance Stocks To BuySimply Wall St.2d agobullish
Johnson & Johnson (JNJ) Wins FDA Nod For First Dual Targeted Head And Neck Therapy24/7 Wall St.2d agoneutral
4 Dividend Raisers With Balance Sheets Strong Enough to Keep Raising Through Any Downturn24/7 Wall St.2d agobearish
5 High-Yield Dividend Stocks That Could Hold Up When the Market FallsGuruFocus.com2d agoneutral
State Street Health Care SPDR (XLV) Adds Eli Lilly and J&J on Nov. 4MT Newswires2d agoneutral
Johnson & Johnson Gets FDA Accelerated Approval for Head and Neck Cancer Drug